Displaying items by tag: uab callahan eye

Cassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).

Congratulations to all the UAB Heersink School of Medicine, UAB Medicine, UAB Health System, and Health Service Foundation leaders who were recognized on the Who’s Who in Healthcare list!
Brian Samuels, M.D., Ph.D., has been appointed chair of the Department of Ophthalmology and Visual Sciences, effective Oct. 1.